Proposal of a magnetic resonance imaging follow-up protocol after cholesteatoma surgery: a prospective study.
Cholesteatoma
MRI
follow-up
non-EPI
recurrence
residual
Journal
Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
pubmed:
6
7
2022
medline:
14
7
2022
entrez:
5
7
2022
Statut:
ppublish
Résumé
Non-echo planar (EPI) diffusion-weighted (DW) MRI has become an effective tool for the follow-up after cholesteatoma surgery and decreased the rate of second-look surgeries. To shed light on the optimal imaging follow-up protocol to detect postoperative residual or recurrent cholesteatoma. 64 patients were included in this prospective study. Three different surgical procedures were considered: canal-wall-up (26 patients), canal-wall-down (20 patients), and obliterative (18 patients). The imaging follow-up protocol included non-EPI DW MRI during the following postoperative periods: 1 month, 6 months, and 1, 3, 5, and 7 years after the primary surgery. MRI-positive lesions were present in 18.75% of patients. 50% of the MRI-positive findings occurred at the 1-month follow-up. The other peak of MRI positivity occurred at the 3-year follow-up. The last MRI-positive finding appeared at the 5-year follow-up. The timing for the imaging protocol proposed by this prospective study to detect recidivism after cholesteatoma surgery stressed the importance of performing non-EPI DW MRI for detecting residual, though rare, disease. Likewise, extending the follow-up to a least 5 years after primary surgery was also recommended to detect any recurrent cholesteatoma that would appear unlikely to be present beyond this time set.
Sections du résumé
BACKGROUND
UNASSIGNED
Non-echo planar (EPI) diffusion-weighted (DW) MRI has become an effective tool for the follow-up after cholesteatoma surgery and decreased the rate of second-look surgeries.
OBJECTIVES
UNASSIGNED
To shed light on the optimal imaging follow-up protocol to detect postoperative residual or recurrent cholesteatoma.
MATERIALS AND METHODS
UNASSIGNED
64 patients were included in this prospective study. Three different surgical procedures were considered: canal-wall-up (26 patients), canal-wall-down (20 patients), and obliterative (18 patients). The imaging follow-up protocol included non-EPI DW MRI during the following postoperative periods: 1 month, 6 months, and 1, 3, 5, and 7 years after the primary surgery.
RESULTS
UNASSIGNED
MRI-positive lesions were present in 18.75% of patients. 50% of the MRI-positive findings occurred at the 1-month follow-up. The other peak of MRI positivity occurred at the 3-year follow-up. The last MRI-positive finding appeared at the 5-year follow-up.
CONCLUSIONS
UNASSIGNED
The timing for the imaging protocol proposed by this prospective study to detect recidivism after cholesteatoma surgery stressed the importance of performing non-EPI DW MRI for detecting residual, though rare, disease. Likewise, extending the follow-up to a least 5 years after primary surgery was also recommended to detect any recurrent cholesteatoma that would appear unlikely to be present beyond this time set.
Identifiants
pubmed: 35787729
doi: 10.1080/00016489.2022.2094464
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM